A number of anti-insulin factors present in the serum of insulin-resistant subjects has been reported. Lowell (1) presented evidence for both insulin-neutralizing and insulin-sensitizing antibodies. De Fillipis and lannaccone (2) and Colwell and Weiger (3) employing salting out methods and Sehon, Kaye, McGarry, and Rose (4) using starch electrophoresis have reported that insulin-neutralizing activity is localized in the y globulin fraction of the serum. Loveless and Cann ((5) , utilizing the technique of electrophoresis convection, observed that insulin-blocking antibody is present in the y globulin.fraction while insulin-sensitizing antibody is recovered with the , 8 globulins. An anti-insulin factor, capable of inhibiting glycogen accumulation by the isolated rat diaphragm, was reported by Field and Stetten (6) to be present in the a and /3 globulin fraction of the serum of diabetic subjects, during episodes of severe insulin-resistant acidosis.
In addition to the factors reported in cases of insulin resistance, an insulin-binding antibody has been demonstrated, by zone electrophoresis and ultracentrifugal fractionation studies employing insulin-I131, to be present consistently in the serum of insulin treated subjects (7, 8) . A study of the distribution of insulin-binding antibody among serum fractions separated with cold ethanol revealed that antibody was restricted to fraction I + III (which is comprised chiefly of /8 and a globulins) in most subjects (9) . In some, antibody was recovered in fraction II (primarily y globulins with a small amount of /l2 globulin) as well as in fraction I + III. In two subjects there were observed a small amount of insulin binding in fraction IV -VI (mainly albumin with a small amount of ,8 and a globulins) as well as more marked binding in the other two fractions. In all cases, bound insulin migrated in the inter -y -8 region on electrophoresis, regardless of the fraction in which the antibody was recovered (9) .
Still another anti-insulin effect is manifested by some sera in inhibiting the degradation of insulin by rat liver homogenates. Williams (10) has recently reported that such inhibition is exhibited by normal plasma but that inhibition is much greater with diabetic than with normal sera.
The different methods employed in the demonstration of anti-insulin factors and in the fractionation of serum for their localization have made it impossible to clearly differentiate among these factors. In the present study the plasma factor associated with apparent inhibition of liver insulinase has been identified with insulin-binding antibody. Inhibitory activity was not observed in normal plasma or in plasma of diabetic subjects who had never received exogenous insulin. The apparent inhibition of liver insulinase activity described in the present report is clearly to be distinguished from that due to direct interference with the liver insulinase system. Inhibition in the present sense applies solely to the protection of insulin from the degrading action of liver insulinase as a consequence of the binding of insulin by insulinbinding antibody.
METHODS
Insulin-I... was prepared from crystalline beef insulin 1 with a specific activity of 3-12 mc. I... per mg. insulin and protected from extensive irradiation damage (11) according to methods previously described (9) . At the higher specific activities, it was not possible to prevent such damage completely and 3 to 5 per cent was frequently found to be altered. Radiation-damaged material binds more or less indiscriminately to all the proteins of control plasma (8) . The extent of binding of insulin by serum antibody was determined by paper electrophoresis or hydrodynamic flow paper chromatography, employing insulin-I"31, according to methods described elsewhere (8) . When insulin-I13. is added to serum or serum protein fractions and subjected to electrophoresis or chromatography on paper, insulin which is not bound to any of the proteins is adsorbed to the paper at the site of application ("origin") (13, 7, 8) but insulin which is bound to any of the proteins migrates away from the origin along with the binding protein. Since some dissociation of the insulinantibody complex may occur during the time required to complete electrophoresis, the presence or absence of binding in specific fractions was frequently determined by simple hydrodynamic flow chromatography (8) , which effects satisfactory movement of the plasma proteins away from the origin in 20 to 30 minutes.
Experimental procedures
Uniinhibited reaction. Insulin concentrations ranging from 0.2 to 500 dg. per ml. were prepared in solutions of 0.067 M phosphate buffer containing serum albumin, 25 to 50 mg. per ml., for the purpose of minimizing adsorption of insulin to the walls of glass containers (14) . Tracer insulin-I131 containing 400 millimicrograms insulin was added to each solution and was taken into account in calculation of the total insulin concentration.
Substrate solutions and preparations of liver homogenate were placed in a constant temperature water bath at 370 C and allowed to reach temperature equilibrium. One-tenth or 0.5 ml. undiluted liver homogenate, or 1.0 ml. of a 1: 10 dilution of liver homogenate was then added to the substrate solutions and incubation at 37°C was continued. Aliquots were taken at various intervals and added to cold 10 per cent trichloracetic acid as described above. For any individual experiment, volumes and dilutions of liver homogenate employed were identical for all substrate solutions.
EFFECT OF LOAD LEVELS OF STABLE INSULN ON LIVER INSULINAE ACTMTY

RESULTS
Uninhibited reaction
The fraction of insulin-I131 degraded as a function of time is plotted for various insulin concentrations in Figure 1 . The initial velocity at each concentration was calculated from the product of the zero time slope and the initial insulin concentration and is plotted as fraction of the maximum velocity vs. substrate concentration in Figure 2 . A Lineweaver-Burk plot (16) of the same data is presented in Figure 3 . Assuming a molecular weight of 12,000 for insulin, the Michaelis-Menten constant (Ki) for this reaction is 7.9 x 10-8 mols per liter and V... is 2.50 X 10-8 mols per minute.
When account is taken of the dilution factor this amounts to 18 ug. min.-' per gram liver. Reaction with serumt or plasma
The serum or plasma of subj ects (diabetic or nondiabetic) who had never received exogenous insulin revealed no evidence of insulin-binding on paper electrophoresis and chromatography and had no influence on the rate of degradation of insulin-I'31 by liver insulinase (Figure 4) .
In the presence of serum or plasma from insulin treated subjects, however, the rate of degradation of insulin-I'13 was inhibited significantly (Figure 4 ). This inhibition was correlated with the presence of insulin binding as demonstrated by paper electrophoresis or chromatography (Figure 4) . When insulin concentrations were increased, resulting in an increased fraction of unbound insulin, the per cent of insulin degraded as a function of time increased, in contrast to the decrease observed in the serum of nontreated subjects ( Figure 5 ) and in the control solutions (Figure 1 ) . The In one such case studied here inhibitory activity was manifested by both II and I + III (Figure 7 ) when both fractions contained antibody and by fraction I + III alone when only that fraction contained antibody (Figure 6 ). DISCUSSION Mirsky, Perisutti, and Dixon (17) have previously made a thorough study of the rat liver insulinase system. The Vma, obtained in the present study (18 ,g. per min. per gram liver) is in good agreement with that (20 jug. per min. per gram liver) obtained by these workers. However, their value for Km is over 100 times as great as that reported here. This discrepancy is probably explained by the fact that Mirsky, Perisutti, and Dixon (17) determined the extent of degradation at the end of 30 minutes and assumed that degradation was linear for all substrate concentrations during this time. The present observations (Figure 1) indicate that this procedure would markedly underestimate the velocities at the lower concentrations and would lead to a gross overestimate of the value for Km.
The correspondence of demonstrable insulin binding and inhibition of liver insulinase activity indicates that the two manifestations of "antiinsulin" activity are identical. This conclusion is J further strengthened by the observation that an increase in insulin concentration, which reduces the ratio of bound to unbound insulin, leads to an increase in the fractional rate of degradation. This observation would be difficult to reconcile with any interpretation that inhibition of liver insulinase activity is associated with some plasma factor unrelated to insulin binding such as "insulinase in--N-hibitor," etc., for if this were the case, increase I in substrate (insulin) concentration should lead MA to a decrease in the fractional rate of degradation. Serum albumin itself has no inhibitory influence on liver insulinase activity (10, 17) nor do a number of other proteins (17) . However, the competitively inhibitory effect on liver insulinase activity of certain other proteins such as glucagon (18) and the competitively inhibitory effect of insulin on liver "adrenocorticotropinase" and liver "glucagonase" activity (18) suggests that liver insulinase is not an absolutely specific enzyme system. The possibility that competitively inhibitory proteins are present in sufficiently high concentration to explain the results obtained in this study is unlikely and furthermore could not account for the increase in fractional rate of degradation with increase in insulin concentration in inhibitory sera.
The present study also fails to confirm the inhibitory influence of diabetic plasma unless the subject has received insulin therapy for some time and has produced insulin-binding antibody, since plasma of nontreated diabetic subjects contains no insulin-binding antibody and fails to inhibit insulinase activity.
The possibility of identity among some of the diverse anti-insulin activities reported by different investigators has been considered elsewhere (9) . The present study indicates that at least two manifestations of "anti-insulin" activity are referable to the same phenomenon, namely binding of insulin by antibody. Whether insulin-neutralizing activity, reported to reside in the y globulin fraction (2) (3) (4) , is identical to insulin-binding globulin, which has been shown to have an elec- 
